Sensex jumps 700 points; Sun Pharma, M&M Finance rally

Market rebounds after a three-session slide

Indian benchmark indices opened the week on a stronger note, rebounding after three consecutive sessions of losses. The move was supported by gains in heavyweight stocks and a positive trend across global markets. In early trade, Sun Pharmaceutical Industries and a set of other index constituents led the advance. Broader markets also outperformed the frontline indices, with midcaps and smallcaps rising more than the Sensex and Nifty. The day’s action highlighted how stock-specific triggers, including earnings and deal news, can lift sentiment even when investors remain watchful on global cues.

Where Sensex and Nifty stood in early trade

At 10.03 am, the BSE Sensex was up 636.20 points, or 0.83%, at 77,300.41. The NSE Nifty50 rose 195.80 points, or 0.82%, to 24,093.75 at the same time. Broader markets outperformed, with the Nifty MidCap and Nifty SmallCap indices rising 1.16% and 1.05%, respectively. The tone was constructive across many counters, while some pockets such as private banks and financial services lagged.

Sector trends: Realty and pharma lead, banks lag

Sectorally, Nifty Realty and Nifty Pharma were the top gainers in early trade. In contrast, Nifty Private Bank and Nifty Financial Services underperformed. This split was visible in the list of index movers: pharma and select industrial names advanced, while some financials remained under pressure. The sectoral rotation also reflected how investors were reacting to fresh corporate updates rather than a single market-wide catalyst.

Sensex movers: Sun Pharma among the key gainers

Among Sensex constituents, Sun Pharmaceutical Industries, Adani Ports, Kotak Mahindra Bank, Tata Steel, and Mahindra & Mahindra were among the major gainers. On the losing side were Axis Bank, Bharat Electronics, Bajaj Finance, and Reliance Industries. The breadth of movers suggested a mixed undercurrent, but gains in a few large stocks were enough to lift the benchmarks decisively in early trade.

Sun Pharma jumps on Organon acquisition announcement

Shares of Sun Pharma surged as much as 7% to ₹1,740 after the company announced a major acquisition of US-listed Organon. The stock opened at ₹1,625 compared with Friday’s close of ₹1,620. Separately, the acquisition was described as marking Sun Pharma’s entry into biosimilars and strengthening its position in several international markets including Europe, China, South Korea, Mexico and Thailand. The sharp move underlined how investors were pricing in potential strategic benefits from the deal, particularly around overseas presence and product opportunities.

Mahindra Finance tops midcap gainers after Q4 profit jump

Mahindra Finance shares surged as much as 9% in late morning trade, emerging as the top BSE midcap gainer. Intraday, the stock logged its best gain in four years after the company said its Q4 net profit rose 55%. The rally also came alongside brokerage rating upgrades that improved sentiment around the counter. The move shows how strong earnings momentum, combined with positive broker actions, can quickly shift market positioning in a stock.

Other buzzing stocks: Paytm hit, banks react to results

In other notable moves, One 97 Communications (Paytm) shares plunged 8% after the Reserve Bank of India cancelled the banking licence of the company’s associate entity, Paytm Payments Bank. Axis Bank and RBL Bank were cited among stocks that were down post-Q4 earnings. These reactions reflected the market’s sensitivity to both regulatory developments and earnings outcomes, especially in financial services where guidance and asset-quality commentary tend to drive short-term price action.

Rupee weakens as equities rise

Alongside the equity rebound, the Indian rupee weakened by 11 paise to 94.27 against the US dollar in early trade. The simultaneous rise in equities and a softer rupee is not unusual, especially on sessions where global risk appetite and local flows are pulling in different directions. Currency moves remain a key variable for import-dependent sectors and companies with foreign currency exposures.

Key market snapshot (early trade)

Market impact: what today’s moves signal

The session’s rebound highlighted two clear drivers. First, stock-specific triggers were strong, led by Sun Pharma’s acquisition news and Mahindra Finance’s Q4 profit growth of 55%. Second, broader risk sentiment improved after three sessions of decline, helping midcaps and smallcaps outperform the benchmarks. At the same time, weakness in some financial stocks and the rupee’s softening showed that not all signals were uniformly positive. For investors, the day reinforced that headline indices can move sharply even when leadership is concentrated in a few names.

Analysis: deal news and earnings regain attention

Sun Pharma’s move showed how large corporate actions can quickly shift near-term market attention toward strategic positioning, especially when the update involves entry into a new area such as biosimilars and expansion across multiple international markets. Mahindra Finance’s jump illustrated the impact of earnings momentum and brokerage upgrades on midcap sentiment. The underperformance of Nifty Private Bank and Nifty Financial Services, alongside declines in stocks like Axis Bank post-results, suggested that earnings scrutiny remained high in banking and lending. Overall, the combination of deal activity and earnings remained the dominant force behind individual stock moves.

What to watch next

Traders are likely to track follow-through buying in pharma and midcaps after the sharp early gains. Sun Pharma will remain in focus for further details around its Organon acquisition, given the market’s immediate positive reaction. Investors will also watch how financial stocks behave as more Q4 outcomes and commentary are digested. Currency moves, including the rupee’s level against the dollar, may also stay on the radar alongside global market cues.

Conclusion

The Sensex and Nifty rebounded strongly in early trade, supported by a rally in Sun Pharma on acquisition news and a sharp jump in Mahindra Finance after a 55% rise in Q4 net profit. Broader markets outperformed, while some banking and financial names lagged. Next cues are likely to come from further corporate updates, earnings reactions, and how global sentiment and the rupee trend evolve through the session.